
With the increasing need for businesses to reduce costs and demonstrate value, there is a requirement to look at all aspects of bio/pharma drug development and manufacturing to achieve efficiency improvements.
Mark Stevens is Operations Director at GxPi.

Published: November 30th 2010 | Updated: